Silverarc Capital Management LLC grew its position in Celldex Therapeutics by 0.9% during the 1st quarter.

Source: https://www.etfdailynews.com/2023/04/22/keybank-national-association-oh-purchases-shares-of-5810-celldex-therapeutics-inc-nasdaqcldx/

Silverarc Capital Management LLC now owns 107,852 shares of the company’s stock worth $2,075,000 after acquiring an additional 6,405 shares during the last quarter.

Source: https://www.etfdailynews.com/2023/01/29/allspring-global-investments-holdings-llc-grows-stock-position-in-syndax-pharmaceuticals-inc-nasdaqsndx/

Silverarc Capital Management LLC now owns 10,956 shares of the biotechnology company’s stock worth $1,578,000 after purchasing an additional 108 shares during the period.

Source: https://www.etfdailynews.com/2023/06/01/dimensional-fund-advisors-lp-boosts-holdings-in-seagen-inc-nasdaqsgen/

Silverarc Capital Management LLC now owns 145,437 shares of the biotechnology company’s stock valued at $881,000 after purchasing an additional 7,477 shares in the last quarter.

Source: https://www.etfdailynews.com/2023/04/09/inspire-investing-llc-buys-17627-shares-of-codexis-inc-nasdaqcdxs/